Merck drug prevents serious infection after marrow transplant: study

(Reuters) - An experimental Merck& Co drug succeeded in preventing clinically serious cytomegalovirus (CMV) following bone marrow transplant and was associated with a lower death rate compared with placebo in a late state study, the company said.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news